Global Conjugate Vaccine Market to Reach USD 21.77 Billion by 2030

Multivalent Platforms, Regulatory Momentum, and Public-Private Partnerships Position Conjugate Vaccines as Cornerstone of Preventive Healthcare Infrastructure Across Developed and Emerging MarketsDelray Beach, FL, Feb. 13, 2026 (GLOBE NEWSWIRE) — The Global Conjugate Vaccines Market is projected to reach USD 21.77 billion by 2030 from USD 15.25 billion in 2025, at a CAGR of 7.4% from 2025 to 2030. This significant growth trajectory reflects escalating demand for advanced immunization solutionsRead More